|
| 对我国基本药物目录中儿童药品纳入及保障的思考 |
| Reflections on the Inclusion and Security of Children's Medicines in China's Essential Medicines List |
| 投稿时间：2024-05-28 修订日期：2024-09-11 |
| DOI： |
| 中文关键词: 国家基本药物目录 世界卫生组织 儿童基本药物目录 儿童用药 |
| 英文关键词: National Essential Medicines List World Health Organization List of Essential Medicines for Children Pediatric drugs |
| 基金项目: |
|
| 摘要点击次数: 31 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：儿童用药是维系儿童生命安全和保障儿童健康事业发展的重要支撑，本文为我国基本药物目录增加儿童药品提供纳入及完善建议。方法：统计分析《国家基本药物目录》中的儿童用药及儿童专用药情况，对比第8版与第9版《世界卫生组织儿童基本药物目录》在药品品种、剂型规格等方面的差异，对比《国家基本药物目录》（2018年版）与《世界卫生组织儿童基本药物目录》（第9版）的差异。结果与结论：第9版《世界卫生组织儿童基本药物目录》与第8版相比，儿童用药的分类、品种、剂型和规格的调整更丰富，合理性有所提高，能够更好地为各国选择和供应儿童基本药物提供指导，满足对基本医疗卫生保健的优先需求。我国《国家基本药物目录》（2018年版）与《世界卫生组织儿童基本药物目录》（第9版）相比，仍存在较大差距，建议相关部门制定符合中国国情的儿童基本药物目录，对儿童这一特殊用药群体进行细致的年龄段划分，鼓励儿童专用剂型、规格的研发。 |
| 英文摘要: |
| OBJECTIVE:Pediatric medication is an important support for maintaining the life safety of children and ensuring the development of children's health. This article provides suggestions for the inclusion and improvement of children's medicines in China's Essential Medicines List. METHODS:Statistical analysis of pediatric medications and children-specific drugs in the National Essential Medicines List, comparison of differences in drug varieties, dosage forms, and specifications between the 8th and 9th editions of the WHO Model List of Essential Medicines for Children, and comparison of differences between the National Essential Medicines List (2018 edition) and the WHO Model List of Essential Medicines for Children (9th edition). RESULTS & CONCLUSIONS:The 9th edition of the WHO Model List of Essential Medicines for Children has made richer adjustments in the classification, variety, dosage forms, and specifications of pediatric medications compared to the 8th edition, improving their rationality. This provides better guidance for countries in selecting and supplying essential pediatric medicines, meeting the priority needs of basic medical and health care. Compared with the 9th edition of the WHO Model List of Essential Medicines for Children,there is still a significant gap in China's National Essential Medicines List (2018 edition). It is recommended that relevant departments develop a pediatric essential medicines list that is in line with China's national conditions, make detailed age group divisions for children, and encourage the research and development of pediatric-specific dosage forms and specifications. This approach will better support the health and development of children by ensuring access to essential medicines tailored to their needs. |
|
View Fulltext
查看/发表评论 下载PDF阅读器 |
| 关闭 |